During the past decade, Azienda Ospedaliera Universitaria Policlinico G. Martino conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 21 clinical trials were completed, i.e. on average, 32.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 13 clinical trials were completed. i.e. 81.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera Universitaria Policlinico G. Martino" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 6 trials, followed by "Celgene" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 69 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Universitaria Policlinico G. Martino" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "A.O. Ospedale Papa Giovanni XXIII" with 1 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator and "AG Mednet Inc." with 1 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Universitaria Policlinico G. Martino" are "Crohn's Disease" (7 trials), "Crohn Disease" (5 trials), "Colitis, Ulcerative" (4 trials), "Cystic Fibrosis" (4 trials) and "Leukemia" (3 trials). Many other conditions were trialed in "Azienda Ospedaliera Universitaria Policlinico G. Martino" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Universitaria Policlinico G. Martino" are "Drug" (62 trials), "Other" (16 trials), "Biological" (8 trials), "Procedure" (6 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Guselkumab" (4 trials), "IVA" (4 trials), "Golimumab" (3 trials) and "Inotersen" (3 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Universitaria Policlinico G. Martino" are 92 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera Universitaria Policlinico G. Martino". undefined are not yet recruiting, 18 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Azienda Ospedaliera Universitaria Policlinico G. Martino, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Universitaria Policlinico G. Martino, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".

Azienda Ospedaliera Universitaria Policlinico G. Martino has several departments that took part in Clinical trials: "U.O.C di Neurologia e Malattie Neuromuscolari Centro Clinico Nemo Sud" - 4 trials, "AOU Policlinico G. Martino Sezione di Endocrinologia" - 2 trials, "Instituto Di Oncologia" - 2 trials